Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Brian Goff

CEO at Agios Pharmaceuticals, Inc. (AGIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M

Reported trades

Filed Stock Type Shares Price Value Since
Apr 6SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 12,472177,604 held (−7%) $34.71 $433K -8.4%
Apr 6SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 6,596184,508 held (−3%) $34.71 $229K -8.4%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 3,870147,733 held (−3%) $28.96 $112K +9.8%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 8,267157,466 held (−5%) $28.96 $239K +9.8%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 5,918164,548 held (−3%) $28.96 $171K +9.8%
Jan 2SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 12,473136,583 held (−8%) $27.09 $338K +17.4%
Jan 2SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 6,230143,103 held (−4%) $27.09 $169K +17.4%
  • Sell

    CEO Brian Goff sold $433K of AGIO at $34.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Brian Goff sold $229K of AGIO at $34.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Brian Goff sold $112K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Brian Goff sold $239K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Brian Goff sold $171K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Brian Goff sold $338K of AGIO at $27.09 — pre-scheduled 10b5-1 plan sale.